Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.67 NOK | -0.68% | -3.10% | -31.45% |
06-20 | Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting | CI |
06-11 | Nykode Therapeutics ASA Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.45% | 449M | |
+16.13% | 122B | |
+19.65% | 113B | |
+21.22% | 26.49B | |
-23.84% | 19.4B | |
-17.47% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- VACC Stock
- News Nykode Therapeutics
- Transcript : Nykode Therapeutics AS, Q3 2022 Earnings Call, Nov 23, 2022